CdLS Research Grants
The CdLS Foundation has a vision and researchers have the determination to find treatments to help individuals with CdLS overcome many of the challenges they face.
The next grant cycle begins January 15, 2017
CdLS is a genetic condition causing a range of medical, developmental and physical challenges, including:
- Gastroesophageal reflux
- Craniofacial defects
- Heart defects
- Self-injurious behavior
- Communications issues (e.g., selective mutism, non-verbal, etc.)
- Developmental delays and intellectual disability
- Behavioral problems and autism
- Feeding problems
CdLS is a cohesinopathy caused by mutations in any one of the following genes: NIPBL, SMC1A, SMC3, HDAC8 and RAD21. Only 70 percent of individuals tested to date have a change in any of the mentioned genes, with the majority having an NIPBL mutation.
Letters of Intent deadline: February 28, 2017
Application deadline: March 31, 2017
Award notification: May 31, 2017
Grant checks mailed: September 1, 2017
Funding is available annually. The next grant cycle begins in early 2017.
The Foundation has previously approved grants for the following projects: